Spectral AI Announces 2023 Fourth Quarter and Full Year Financial Results
27 mars 2024 16h10 HE
|
Spectral AI, Inc.
2023 Research & Development Revenue of $18.1 Million Expected to Increase to $28.0 Million in 2024 Commercialization Underway with Revenue Expected in 2H 2024 for DeepView AI®-Burn Indication in...
Spectral AI Secures Access to $12.5 Million of New Equity Capital
20 mars 2024 14h45 HE
|
Spectral AI, Inc.
Issuance of Convertible Instrument Balances Certainty, Timing, and ExecutionCapital Supports Strategic Imperatives and Commercialization Initiatives DALLAS, March 20, 2024 (GLOBE NEWSWIRE) --...
Spectral AI Announces Receipt of $1 Million of Financing for Spectral IP, Inc., its Intellectual Property Subsidiary Focused on the Broader Artificial Intelligence Ecosystem
19 mars 2024 08h00 HE
|
Spectral AI, Inc.
DALLAS, March 19, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...
Spectral AI Schedules 2023 Fourth Quarter and Full Year Financial Results and Conference Call
13 mars 2024 08h00 HE
|
Spectral AI, Inc.
DALLAS, March 13, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...
Spectral AI Announces New US Government Contract to Further Accelerate the Development of the Handheld Version of DeepView™ Wound Imaging System
12 mars 2024 08h00 HE
|
Spectral AI, Inc.
DALLAS, March 12, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...
Spectral AI Announces Intellectual Property Subsidiary to Focus on the Broader AI Healthcare Ecosystem
07 mars 2024 08h00 HE
|
Spectral AI, Inc.
DALLAS, March 07, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...
Spectral AI Appoints Peter M. Carlson as CEO
29 févr. 2024 17h30 HE
|
Spectral AI, Inc.
Appointment Paves the Way for Company’s Next Chapter in Commercialization Phase of AI-Powered DeepView Device for Predictive Wound Care Carlson Brings Proven Track Record of Operating and Financial...
Spectral AI to Participate in Upcoming Investor Conferences
28 févr. 2024 08h00 HE
|
Spectral AI, Inc.
DALLAS, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...
Spectral Receives UKCA Authorization for Burn Indication Expected Commercialization 2nd Half 2024
22 févr. 2024 08h00 HE
|
Spectral AI, Inc.
DALLAS, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...
Spectral AI Appoints Dr. J. Michael DiMaio to Board of Directors
12 févr. 2024 08h00 HE
|
Spectral AI, Inc.
DALLAS, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on the unmet need for improved medical...